Xcout Intel
Umoja Biopharma, Inc.
Umoja Biopharma is a biotechnology research company headquartered in Seattle, Washington, focused on developing next-generation immunotherapies.
Subscribe to see Umoja Biopharma, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Umoja Biopharma, Inc. at a glance
Umoja Biopharma, Inc. is a biotechnology company headquartered in United States. It has raised at least $310M across the 2 funding rounds on record. Its most recent funding round, Series C, raised $100M in January 2025. Xcout tracks 5 named people at Umoja Biopharma, Inc., including Andrew Scharenberg (Chief Executive Officer). Xcout recorded 16 job postings from Umoja Biopharma, Inc. in the last 90 days, naming tools such as NetSuite, SAP, Workday.
Umoja Biopharma, Inc. leadership
- Andrew ScharenbergChief Executive Officer
- Nate HardyChief Financial Officer
- Andrew Scharenbergco-founder and Chief Executive Officer
- Dr. Athena CountouriotisBoard Member
- Dr. Marcela MausBoard Member
Umoja Biopharma, Inc. funding rounds
At least $310M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $100M | 14 named | |
| Series C | $210M | 14 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Umoja Biopharma, Inc.
Xcout recorded 16 job postings from Umoja Biopharma, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Umoja Biopharma, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Umoja Biopharma, Inc.'s hiring signals →
Investors
Tech stack
Umoja Biopharma, Inc. competitors
A few of Umoja Biopharma, Inc.'s closest competitors — see the full list of competitors and alternatives →
Aptevo Therapeutics Inc. is a public, clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing novel bispecific and trispecific immunotherapies for immuno-oncology.
Outpace Bio, Inc. is a biotechnology company headquartered in Seattle, Washington, specializing in AI-powered protein design to advance cell therapies.
InduPro is a biotechnology company focused on advanced science and proximity-based therapeutics that bring cell surface proteins together for novel drug designs. The company is headquartered in Seattle, Washington.
Nexus Biologics, SPC is a privately held biotechnology research company founded in 2019 and headquartered in Seattle, Washington.
iOmx Therapeutics AG is a biopharmaceutical company located in Martinsried near Munich, Germany, dedicated to discovering and developing next-generation targeted cancer immunotherapies.
Immune Design Corp. is a clinical-stage immunotherapy company with offices in Seattle, Washington, and South San Francisco, California, specializing in novel drug discovery and treatment technologies.
Get Umoja Biopharma, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Umoja Biopharma, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Umoja Biopharma, Inc. in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access